Site Search
Professionals 626 results
Capabilities 89 results
Practice Area
Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022).
Practice Area
Winston’s Intellectual Property (IP) Practice is one of the most active and highly regarded in the United States per Chambers USA, Benchmark Litigation US, and Best Law Firms®, among other ranking organizations. Our team features some of the country’s best IP lawyers, attorneys with the technical abilities to litigate and try highly complex IP disputes, and technical lawyers who provide critical advisory services.
Practice Area
Winston & Strawn’s private equity attorneys provide strategic advice and legal counsel to middle-market private equity funds, hedge funds, family offices, real estate funds, alternative asset managers, portfolio companies, and institutional investors. We have one of the broadest and most active national middle-market private equity practices in the U.S.
Experience 25 results
Experience
|June 25, 2025
Winston Secures Federal Circuit Affirmance of 101 Victory for Polycom
Experience
|April 30, 2025
Insights & News 3,603 results
Webinar
|July 15, 2025
The Revival of Most-Favored-Nation Pricing: What Pharma Needs to Know
Join us for a webinar exploring the evolving antitrust landscape as it intersects with drug pricing policy and regulation under the current administration. Reviving the “most-favored-nation” drug pricing principle of the prior Trump administration, this administration is leveraging antitrust tools to address high pharmaceutical costs, signaling a shift toward increased regulatory scrutiny of market power and pricing disparities. Our attorneys will cover the latest executive orders and proposed agency actions, potential implications for pharmaceutical companies and the broader healthcare industry, and how to navigate this changing regulatory environment.
Competition Corner
|July 15, 2025
|3 Min Read
Colorado recently became the second state, after Washington, to enact the Uniform Antitrust Premerger Notification Act (UAPNA) and establish a general state-level premerger notification requirement.
In the Media
|July 14, 2025
|2 Min Read
Aaron Benjamin Joins Winston & Strawn as Structured Finance Partner
Winston & Strawn recently announced the addition of Aaron Benjamin to the firm’s Charlotte and New York offices as a partner in the Transactions Department and a member of the Structured Finance Practice. Aaron represents many of the largest U.S. and foreign banks in commercial real estate warehouse lending deals. He is recognized as a market leader in bank-side representation in pooled lending transactions backed by commercial mortgage loans and in structured repurchase transactions backed by asset-backed securities, including mortgage backed securities, CRE CLO bonds and commercial bank loan and middle market CLO bonds.
Other Results 67 results
Law Glossary
Colloquially referred to as the “patent dance,” the BPCIA provides a framework that includes certain steps and a schedule during which the applicant and reference product sponsor exchange confidential information disclosed in the aBLA. During the patent dance, the applicant and sponsor identify the patents that could be litigated in the future during two potential phases of litigation. In the first phase, the sponsor can allege infringement of a subset of the patents identified during the patent dance. The second phase begins after the sponsor receives the Notice of Commercial Marketing from the applicant. During this second phase, the sponsor can assert any remaining patents that were not asserted in the first phase.
Law Glossary
What Is the Patent Trial and Appeal Board?
The Patent Trial and Appeal Board (PTAB) is a tribunal within U.S. Patent and Trademark Office. The PTAB oversees trial proceedings, namely: inter partes review (IPR), post-grant review (PGR), covered business method (CBM) review, and derivation proceedings. The Board also hears appeals from adverse patentability decisions by patent examiners in original applications, reissues, and reexaminations. And, while phasing out since the passage of the America Invents Act (AIA) in 2011, the PTAB is also responsible for deciding interferences. The PTAB was previously referred to as the Board of Patent Appeals and Interferences and was renamed by the AIA.